CVEvulnerability
CVE-2026-21923
6.5 MEDIUM
Official page ↗
- Status
- Analyzed
- Published
- 2026-01-20
- Last modified
- 2026-06-17
- Assigner
- [email protected]
- CVSS 3.1 ([email protected])
- 6.5 MEDIUM — CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Description
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
Affected configurations
• oracle life sciences central designer 7.0.1.0
References
- https://www.oracle.com/security-alerts/cpujan2026.html Vendor Advisory